Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasR I Fisher, D L Longo, V T DeVita, et al.Journal of Dairy Science|April 25, 2009
Genetic and environmental factors that affect gestation length in dairy cattleH D Norman, J R Wright, M T Kuhn, et al.The American Journal of Medicine|October 1, 1981
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's diseaseR L Schilsky, R J Sherins, S M Hubbard, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early resultsR B Jones, C E Myers, A M Guarino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 1991
The calculation of actual or received dose intensity: a comparison of published methodsD L Longo, P L Duffey, V T DeVita, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's diseaseJ A Kant, S M Hubbard, D L Longo, et al.Blood|July 1, 1981
Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphomaR I Fisher, S M Hubbard, V T DeVita, et al.Annals of Internal Medicine|May 1, 1980
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's diseaseR I Fisher, V T DeVita, F Bostick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Twenty years of MOPP therapy for Hodgkin's diseaseD L Longo, R C Young, M Wesley, et al.Annals of Internal Medicine|March 1, 1983
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapyR I Fisher, V T DeVita, S M Hubbard, et al.Pageof 5